News

Sintetica SA premiata come azienda farmaceutica svizzera dell’anno
Alfa Wassermann and APR business partnership grows stronger: Dicloreumdol®makes it to the Italian market

Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid® Ge

APR and Angelini strengthen their partnership in wound care with the launch of Nexodyn® AOS Wound Care Solution in the USA

BORSE DI STUDIO HELSINN ADVANCED SYNTHESIS 2016/2017 PER 11 STUDENTI DEL CANTON TICINO PER UN VALORE COMPLESSIVO DI 55.000.- CHF

New scientific data publication on Nexodyn® presented by Key Opinion Leaders

Linkedin